Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Aldose Reductase and Taurine, and Cancer Immunotherapy and Biomarkers.
Error-corrected flow-based sequencing at whole-genome scale and its application to circulating cell-free DNA profiling
Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment
Incidence of checkpoint inhibitor-associated inflammatory arthritis, immunomodulation and mortality in cancer patients on immunotherapy: a retrospective cohort study
Advancements in small cell lung cancer
Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I–III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial
Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial
Mechanisms of Ischemic Stroke in Patients with Cancer: A Prospective Study
Radiation Therapy for Small-Cell Lung Cancer: ASCO Guideline Endorsement of an ASTRO Guideline
MET Alterations Are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung Cancer
Intestinal estrogen receptor beta suppresses colon inflammation and tumorigenesis in both sexes
The lung microenvironment: an important regulator of tumour growth and metastasis
Colitis‐induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity
Brigatinib in Patients With Alectinib-Refractory ALK-Positive NSCLC